<DOC>
	<DOCNO>NCT00364429</DOCNO>
	<brief_summary>This study design compare [ 123 ] I-CNS 1261 bind NMDA receptor healthy volunteer different subgroup schizophrenic patient . Investigation potential influence antipsychotic concomitant medication [ 123I ] CNS 1261 binding also relevant.Fifteen healthy subject ( male female non-child bearing potential ) recruit 40 schizophrenic patient divide 3 subgroup indicate : Subgroup ) treatment-naive , ( n=10 ) ; Subgroup b ) stable treatment risperidone ( without criterion deficit syndrome SDS scale , ( n=15 ) ; Subgroup c ) stable treatment risperidone fit criterion deficit syndrome SDS scale , ( n=15 ) .</brief_summary>
	<brief_title>SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Inclusion criterion : Righthanded Smoker Healthy volunteer schizophrenic patient diagnose DSM IV criterion . Treatment naive patient Risperidone treatment 2 month receive depot neuroleptic last year . Women childbearing potential must agree acceptable method birth control . Exclusion criterion : Any clinically laboratory significant abnormality . Subjects receive radiation dose activity 10 mSv 3 year period . Heart pacemaker , metallic prosthesis metallic body implant . History presence CNS condition . History substance dependence . History suffers claustrophobia . Positive test HBV ( hepatitis B virus ) , HCV ( hepatitis C virus ) HIV . Pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>schizophrenic patient</keyword>
	<keyword>SPET</keyword>
	<keyword>NMDA receptor</keyword>
	<keyword>ligand [ 123 ] I-CNS 1261</keyword>
</DOC>